Shared publicly  - 
 
With Sofinnova's Lars Ekman at the helm, San Diego's Sophiris Bio advances highly targeted drug for shrinking enlarged prostate gland. If successful, therapy offers a treatment for BPH without affecting joy of sex. 
http://www.xconomy.com/san-diego/2012/07/10/sophiris-moves-to-unlock-blockbuster-potential-in-new-prostate-drug/
1
Add a comment...